Join
Live feed
·
INSIDERFilingvia Quantisnow
PTC Therapeutics Inc. logo

EXEC. VP AND CLO Boulding Mark Elliott sold $209,763 worth of shares (3,019 units at $69.48), decreasing direct ownership by 3% to 105,212 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PTCT· PTC Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PTCT (PTC Therapeutics Inc.) and more on Quantisnow.